Arnlea renames its software product to reflect move to SaaS  

01/05/2023
Andy Powrie (COO Arnlea Systems)

ARNLEA Systems Ltd, a global leader in industrial mobile software for tracking, inspection, and maintenance, today announced that it has renamed its flagship product.

The software suite formally known as IntrinsixIM, IntrinsixMM and IntrinsixEX will now all be encompassed into one product known as Nexar, reflecting the company’s move to a Software-as-a-Service (SaaS) delivery model. The new name, Nexar, represents a fresh direction for the product and highlights Arnlea’s commitment to innovation and providing the latest technology solutions to its clients. With the transition to a SaaS delivery model, Nexar will provide clients with a more flexible and scalable solution, enabling them to manage their assets and data more efficiently and cost-effectively. 

Andy Powrie, Chief Operating Officer at Arnlea, commented: “We migrated to a SaaS model last year and, with the product now becoming more established with our customers and building momentum in the market, the time is right to introduce Nexar. Nexar represents a new era, as we have moved towards a more agile and modern software delivery model. We’re excited about the opportunities this presents to our clients, and we look forward to working with them to help them overcome their asset management challenges”. 

Arnlea’s Head of Product, Andrew Ayton added: “Nexar offers a range of features and benefits to our customers, including real-time data access using cloud software, improved analytics and reporting, and greater collaboration and visibility across the asset management process. The software is also designed to seamlessly integrate with ERP systems such as SAP or IBM Maximo, which are widely used around the world”.

“This new chapter for Arnlea and Nexar, is further testament to our commitment to being at the forefront of the industry and being able to unlock strategic efficiencies that optimise our clients’ operations”.

The Latest Stories

Entrepreneurial success at latest Startup Showcase as RGU secure future funding
Global leaders agree to launch first international network of AI Safety Institutes to boost understanding of AI
Pneumagen Presents Positive Phase 2 Influenza Human Challenge Study data on Neumifil, its Broad-Spectrum Antiviral Drug, at the American Thoracic Society (ATS) 2024 Conference
Glasgow to welcome global space industry to first ever space-comm expo Scotland